Abstract

Amelogenesis imperfecta (AI) is a clinically and genetically heterogeneous group of diseases characterized by enamel defects. The authors have identified a large consanguineous Moroccan family segregating different clinical subtypes of hypoplastic and hypomineralized AI in different individuals within the family. Using targeted next-generation sequencing, the authors identified a novel heterozygous nonsense mutation in COL17A1 (c.1873C>T, p.R625*) segregating with hypoplastic AI and a novel homozygous 8-bp deletion in C4orf26 (c.39_46del, p.Cys14Glyfs*18) segregating with hypomineralized-hypoplastic AI in this family. This study highlights the phenotypic and genotypic heterogeneity of AI that can exist even within a single consanguineous family. Furthermore, the identification of novel mutations in COL17A1 and C4orf26 and their correlation with distinct AI phenotypes can contribute to a better understanding of the pathophysiology of AI and the contribution of these genes to amelogenesis.

Highlights

  • Amelogenesis imperfecta (AI) represents a group of conditions, genomic in origin, which affect the structure and clinical appearance of the enamel of all or most the teeth in a more or less equal manner, and which may be associated with morphologic or biochemical changes elsewhere in the body [1]

  • AI is a developmental condition of the dental enamel that shows autosomal dominant, autosomal recessive, sexlinked and sporadic inheritance patterns, as well as sporadic cases

  • Many classifications of AI have evolved since the original division into hypoplastic and hypocalcified types in 1945 (See Table 1) [1,2,4,5,6,7,8,9,10,11,12,13]

Read more

Summary

Schultze C

8. Witkop CJ Jr, Rao S: Inherited defects in tooth stucture. In The clinical delineation of birth defects. 9. Winter GB, Brook AH: Enamel hypoplasia and anomalies of the enamel. Sundell S, Koch G: Hereditary amelogenesis imperfecta. I. Epidemiology and clinical classification in a Swedish child population.

11. Witkop CJ Jr
37. Crooks MC
44. Weerheijm KL
Findings
48. Wright JT

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.